Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

MBX Capital

Data updated

Claymont, Delaware (official mail), United States

MBX Capital is an early-stage venture capital firm focused on deep health companies, with an official FAQ stating it is agnostic to sector so long as the company has a clear deep health vision. The firm says it typically invests in companies’ first or second institutional rounds and can also participate in later-stage financings. Its public mailing address is in Claymont, Delaware, United States.

In the psychedelic ecosystem, MBX Capital is relevant because its portfolio page includes Journey Colab, described as building psychedelic therapies for addiction, alongside other mental-health and neuro-related companies. That makes MBX Capital a broader deep-health investor with at least one public psychedelic-adjacent portfolio company and a stated willingness to invest globally when the opportunity fits.

Investor Context

Venture Capital

Investment Context

This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.

Public Portfolio Examples

MBX Capital presents itself as a deep health venture firm that makes early institutional investments, typically writing $1 million to $4 million checks and often leading or co-leading rounds while also following on in larger financings. Although it is not described as a dedicated psychedelic fund, its portfolio includes Journey Colab, a company focused on psychedelic therapies for addiction, which places it within the broader psychedelic-adjacent investment landscape. The firm says most of its investments are in the United States, but it can invest anywhere in the world for the right opportunity.

Investor Type

Venture Capital Fund

Geographic Scope

Global

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement

Active

Investment Stage Focus

SeedSeries A/BGrowth / Late Stage

Investment Focus Areas

Drug Development

Investment Orientation

Engagement Status

Active

Investor Type

Venture Capital Fund

Investment Website

Recorded Investments

Journey Colab

Jan 1, 2021

Partnered

Public portfolio entry describes the company as building psychedelic therapies for addiction.

MBX Capital | Deep Health VC

Quick Facts

HQ
Claymont, Delaware (official mail), United States
Website
Visit